Review Of WHO Mechanism To Fight Substandard Medicines Postponed Until 2017
World Health Organization delegates today agreed in committee to postpone until 2017 the review of a mechanism that had been set up to help countries deal with substandard and fake medicines.
WHO Debates Plan To Fight Antibiotic Resistance
World Health Organization members this week are debating a plan to address the global problem of increasing resistance to existing antibiotics and the lack of new treatments to replace them. Today, discussions on antimicrobial resistance went to informals to try to resolve outstanding issues.
Two UN Agencies Come Out In Support Of Extension Of TRIPS LDC Waiver
The United Nations Development Programme and the Joint UN Programme on HIV/AIDS have issued a joint statement supporting a request by least-developed countries to extend a waiver allowing them to abstain from enforcing patents on pharmaceutical products.
At WIPO, 11 Members Sign New Act Protecting GIs, More To Follow
Today, the signing ceremony of the new World Intellectual Property Organization agreement to protect geographical indications was held. On the first day, 11 members, mostly current Lisbon members, signed the Geneva Act of the Lisbon Agreement for the Protection of Appellations of Origin and Geographical Indications.
European Council Takes Action To Advance Marrakesh Treaty For Blind Persons
The European Council of member states yesterday adopted a decision asking the European Commission to draft legislation on Europe’s ratification of the Marrakesh Treaty on increasing access to publications for blind and visually impaired readers. The Marrakesh Treaty was concluded at the World Intellectual Property Organization in 2013, and WIPO members have been in the […]
Five Challenges Filed Against Gilead Patent Claims For Hepatitis C Drug
Pharmaceutical company Gilead Sciences has been noted first for developing a treatment for hepatitis C, which afflicts tens of millions around the world, and then for pricing it at jaw-dropping prices ($1000 per pill) in the United States and elsewhere. Now a group of health advocates has challenged Gilead's patent applications in five emerging economies.
New Act Protecting Geographical Indications Adopted At WIPO
Today, a small number of World Intellectual Property Organization members adopted a new Geneva Act of a treaty protecting appellations of origin and geographical indications. The Act is the revision of a previous treaty which only covered appellations of origin. This adoption was made to the dismay of other WIPO members, which despite efforts to accommodate their views could not reconcile being denied the right to vote in a United Nations body. They said the agreement among a few members could affect all.
Lisbon Members Near Completion Of New Act On Geographical Indications
[Update: the new Act has been adopted. More to come.] After a week of drafting, a handful of World Intellectual Property Organization members – with often divergent input from other WIPO members – are close to concluding a new international agreement on the protection of geographical indications.
Did The WHO Just Invite Corporates To Set Health Policy?
From the New Minute: The Director General of the World Health Organisation (WHO) Dr. Margaret Chan has invited the private sector, civil society and academia among others, to join a dialogue on how non-state players can work with the global body to enhance public health work. A leading voice in this configuration is the United States-based Global Health Council (GHC) whose strong and spirited response to the invitation has set the cat among the pigeons in some countries (including reportedly with India) and certain sections of non-governmental organisations (NGOs).
Statement: Blumenthal Offers Amendment On Trade Transparency
Senators Blumenthal, Brown, Baldwin, and Udall introduced today a trade negotiation transparency bill that would require that all formal U.S. proposals for trade agreement restrictions on domestic regulations be posted on a website. This is a common sense policy that should be broadly supported. The bill would require policies similar to the transparency policies currently followed by the European Union and by intergovernmental organizations that set similar minimum regulatory standards. But it would be a major change in the current process for trade negotiations followed by the U.S. Trade Representative, which are infamously secretive, write Sean Flynn and David Levine.